Skip to main content
Figure 5 | Arthritis Research & Therapy

Figure 5

From: Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates

Figure 5

Percentage changes in serum tartrate-resistant acid phosphate-5b (TRACP-5b) at 6, 12 and 18 months after the start of treatment in the bisphosphonate (Bis) and Bis + statin groups. Circles represent the Bis group and triangles represent the Bis + statin group. Significant increases in serum TRACP-5b were observed at 6, 12 and 18 months in the Bis + statin group, but in the Bis group a significant increase was only observed at 18 months. *P < 0.05, *P < 0.01, ***P < 0.001, for comparison to baseline for each group.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us